Quick Answer
HERON THERAPEUTICS, INC. /DE/ reported Cash And Cash Equivalents At Carrying Value of $28.65 million for the year ending 2025.
- HERON THERAPEUTICS, INC. /DE/ showed an increase of +11.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from HERON THERAPEUTICS, INC. /DE/'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), HERON THERAPEUTICS, INC. /DE/'s Cash And Cash Equivalents At Carrying Value has grown by 187.4%.
- Historical annual values: Fiscal year 2025: $28.65 million | Fiscal year 2024: $25.80 million | Fiscal year 2023: $28.68 million | Fiscal year 2022: $15.36 million | Fiscal year 2021: $90.54 million | Fiscal year 2020: $105.14 million | Fiscal year 2019: $71.90 million | Fiscal year 2018: $31.84 million | Fiscal year 2017: $144.58 million | Fiscal year 2016: $13.41 million | Fiscal year 2015: $75.18 million | Fiscal year 2014: $72.68 million | Fiscal year 2013: $72.29 million | Fiscal year 2012: $53.51 million | Fiscal year 2011: $17.97 million | Fiscal year 2010: $2.11 million | Fiscal year 2009: $7.59 million | Fiscal year 2008: $9.97 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: